2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$4.53-$0.010 (-0.22%)
Price as of Aug 21, 2026 7:30 PM EDT- $171.9MMarket Cap
- -40.26%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$4.53-$0.010 (-0.22%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.54 | ||
Change | +$0.02 (+0.44%) | ||
Open | $4.58 | ||
High | $4.70 | ||
Low | $4.50 | ||
Previous Close | $4.52 | ||
Volume | 90,553 | ||
30-Day Average Volume | 132,896 | ||
1-Week Change | -3.81% | ||
1-Month Change | -2.16% | ||
1-Year Change | -40.26% | ||
3-Year Change | -50.16% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.9M | ||
Total Assets | $229.5M | ||
Market Cap | $171.9M | ||
Enterprise Value | $166.5M | ||
Period: QTR TTM FY | |||
Revenue | $11.5M | ||
Net Income | -$6.2M | ||
Free Cash Flow | $855,000.00 | ||
EBIT | $1.5M | ||
EBITDA | $4.3M | ||
Net Working Capital | N/A | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | 15 | ||
P/B | -5 | ||
P/E | -24 | ||
PEG | -0 | ||
Price/Free Cash Flow | 201 | ||
Price/Operating Cash Flow | 229 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue